Molecules / Tacrolimus / China

Tacrolimus API manufacturers in China

CAS 104987-11-3 ATC D11AH01 Updated 9 July 2026
7
China-based manufacturers with an active filing of 25 worldwide
$47300.40
median export price per kg, all origins $35295.91 to $66852.03 · 19 exporters · 2025
Showing 7 of 7 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

01
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tacrolimus, filing since 2020. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Wuxi Fortune Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tacrolimus, filing since 2024. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Hangzhou Zhongmei Huadong Pharmaceutical

China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tacrolimus, filing since 2016. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Fujian Kerui Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tacrolimus, filing since 2008. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Lunan New Time Bio-Tech

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tacrolimus, filing since 2023.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Chengdu Yacht Biotechnology

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tacrolimus, filing since 2024.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
07

Hisun Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for tacrolimus, filing since 2024.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile

How this list is built

This page filters the worldwide Tacrolimus manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Who makes tacrolimus?

Ask Fred which manufacturers are on record for tacrolimus and what filings they hold.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

All Tacrolimus manufacturers

Worldwide 25

Also made in China

Tirzepatide 15 Carfilzomib 11 Clindamycin 10 Iohexol 10 Retatrutide 10 Semaglutide 10 Azilsartan Medoxomil 9 Docetaxel 9

All API manufacturers in China